News

MetLife (MET) reported $17.02 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 5.5%. EPS of $1.83 for the same period compares to $1.52 a year ago.

The reported revenue represents a surprise of -3.81% over the Zacks Consensus Estimate of $17.69 billion. With the consensus EPS estimate being $1.83, the company has not delivered EPS surprise.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how MetLife performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Total Adjusted Revenue- Latin America: $1.88 billion versus the three-analyst average estimate of $1.95 billion. The reported number represents a year-over-year change of +7.5%.
• Adjusted Revenue- Corporate & other- Premiums: $6 million versus the three-analyst average estimate of $16.40 million. The reported number represents a year-over-year change of -62.5%.
• Total Adjusted Revenue- EMEA: $674 million versus the three-analyst average estimate of $650.81 million. The reported number represents a year-over-year change of +7.7%.
• Total Adjusted Revenue- Asia: $2.85 billion versus $2.86 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +6.6% change.
• Revenue- Premiums: $10.05 billion versus $10.88 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +4.8% change.
• Revenue- Other Revenues: $674 million versus the five-analyst average estimate of $633.59 million. The reported number represents a year-over-year change of +5.5%.
• Revenue- Universal life and investment-type product policy fees: $1.25 billion compared to the $1.33 billion average estimate based on five analysts. The reported number represents a change of -3.2% year over year.
• Revenue- Net investment income: $5.44 billion compared to the $4.93 billion average estimate based on five analysts. The reported number represents a change of +17% year over year.
• Adjusted Revenue- Retirement & Income Solutions- Premiums: $675 million versus $1.64 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +34.7% change.
• Adjusted Revenue- Retirement & Income Solutions- Universal life and investment-type product policy fees: $75 million compared to the $86.40 million average estimate based on three analysts. The reported number represents a change of -5.1% year over year.
• Adjusted Revenue- Retirement & Income Solutions- Net investment income: $2.09 billion versus the three-analyst average estimate of $1.91 billion. The reported number represents a year-over-year change of +15.2%.
• Adjusted Revenue- Retirement & Income Solutions- Other Revenues: $63 million versus $68.46 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -7.4% change.

View all Key Company Metrics for MetLife here>>>

Shares of MetLife have returned -2.9% over the past month versus the Zacks S&P 500 composite's -4.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.